TD Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
TD Capital Management's NVO Position: Q1 2026 in Review
TD Capital Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 212 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #500.
TD Capital Management first reported a position in NVO in Q1 2020 and has held it in 23 quarters since. The position peaked at $54.7K in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- TD Capital Management held 212 shares of Novo Nordisk worth $7.81K as of Q1 2026.
- TD Capital Management left its Novo Nordisk share count unchanged in Q1 2026.
- Novo Nordisk made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #500 holding.
- TD Capital Management first reported a position in Novo Nordisk in Q1 2020 and has held it in 23 quarters since.
- TD Capital Management's Novo Nordisk position peaked at $54.7K in Q2 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.